Bernstein initiates Keurig Dr Pepper with Outperform rating and $38 price target

AnalystCorporate Action
โดย Insider Monkey·Read original
Summary · why it matters

Bernstein initiated coverage of Keurig Dr Pepper with an Outperform rating and a $38 price target on June 11, 2026. The firm highlighted the company's outstanding functional beverages portfolio and noted that while a challenging integration is underway, the associated risks are well understood and priced in. On the same day, JAB BevCo, a subsidiary of JAB Holding, sold its remaining stake of approximately 59.1 million shares, or about 4.3% of outstanding common stock, through an unregistered block trade by J.P. Morgan Securities. Keurig Dr Pepper earlier reported first-quarter adjusted earnings per share of 39 cents, beating the consensus estimate of 37 cents, on revenue of $3.98 billion, which also exceeded expectations.

Impact on stocks 2

Consumer Staples▲ · 1 stocks
Keurig Dr Pepper Inc
KDP
▲ PositiveCapitalrelevance

Bernstein initiated with Outperform and $38 PT, and Q1 earnings beat estimates.

Digital Finance & Tokenization▲ · 1 stocks

Off-coverage companies 3

JAB BevCo B.V.Private▼ Negative
Capitalrelevance

JAB BevCo sold its remaining 4.3% stake in Keurig Dr Pepper, indicating divestment.

JAB Holding CompanyPrivate▼ Negative
Capitalrelevance

JAB Holding's subsidiary sold its stake, reflecting a reduction in its investment.

J.P. Morgan Securities LLCPrivate± Mixed
relevance

© 2026 MarketDXNews